Notes

How Here's why Ayr Wellness is better than Curaleaf - Cantech Letter can Save You Time, Stress, and Money.


<h1 style="clear:both" id="content-section-0">Not known Facts About Investors in cannabis companies burned by stock-market<br></h1>
<br>
<p class="p__0">Unique Function Acquisition Corporations or SPACs have a bad rap. Perverse incentives, sky high valuations and unreasonable business strategies prevail. But https://highyields.com of a SPAC structure can in fact be helpful, especially in a capital constrained market like cannabis. Thinking about the dearth of financing choices in cannabis, SPAC structures are super helpful to fix the capital requirements of quick growing companies.</p>
<br>
<p class="p__1">I discussed the business in 2019 highlighting the chance when the stock was close to $16 per share. Quick forward to the present and I'm amazed at how far the company has can be found in two short years. This little $125 million SPAC is now at a $110 million in EBITDA annualized run rate and is anticipating $800 million profits and $300 million in EBITDA for 2022.</p>
<br>
<p class="p__2">What I like even more about the most recent statements is that it is clear the business is not slowing down however is accelerating their growth and financial investments. One would believe with such a performance history that AYR would be trading at some extravagant multiple of earnings and money circulation, especially since the company on a net basis barely has any debt.</p>
<br>
<img width="437" src="https://ih.advfn.com/p.php?pid=staticchart&amp;s=AYRWF&amp;p=3&amp;t=43&amp;showctype=1">
<br>
<div itemscope itemtype="http://schema.org/ImageObject">
<img class="featurable" style="max-height:300px;max-width:400px;" itemprop="image" src="https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/elsa-olofsson-2zrxd7akzgy-unsplash.jpg?width=720" alt="Ayr Wellness Reports Third Quarter 2021 Results"><span style="display:none" itemprop="caption">Here's why Ayr Wellness is better than Curaleaf - Cantech Letter</span>
</div>
<br>
<br>
<h1 style="clear:both" id="content-section-1">Get This Report on Got $5,000? These Are 2 of the Best Growth - User Walls<br></h1>
<br>
<p class="p__3">AYR trades at 2. 5 times 2022 income and 7 times 2022 EBITDA quotes. And the company is growing at over 100% year over year! In 2023, the business must easily top $1 billion in revenue and potentially more than $400 million in capital, making its 2023 several a ridiculous 5 times capital.</p>
<br>
<div itemscope itemtype="http://schema.org/ImageObject">
<img class="featurable" style="max-height:300px;max-width:400px;" itemprop="image" src="https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2012/mathematical-michael-qen7jtbtktk-unsplash.jpg" alt="Lorimer Wilson Blog - AYR Wellness Q1 Financials Reflect Company's Strategic Transformation - Talkmarkets"><span style="display:none" itemprop="caption">Ayr Wellness Stock (CSE: AYR.A) (OTCQX: AYRWF) – Investor Dashboard – New Cannabis Ventures</span>
</div>
<br>
<br>
<p class="p__4">Why? Since in the capital constrained United States cannabis market, AYR can use its size, scale and access to capital to purchase smaller companies and continue to grow. It is purchasing sub-scale companies at 5 times EBITDA that with the development and access to capital is really like 2-3 times a couple of years out.</p>
<br>
<p class="p__5">What I enjoy most about following AYR is how disciplined they are when purchasing business and using shareholder capital. CEO Jonathan Sandelman and Head of Technique and M&amp;A Jamie Mendola have actually put together a string of deals that have remarkably grown the business's scale and geographic footprint. Their Liberty Health acquisition was simply inspired.</p>
<br>

Website: https://highyields.com/cannabis-companies/ayr-wellness/